6-(3,5-dibromo-4-methoxyphenyl)-3-ethylsulfanyl-2,6-dihydro-[1,2,4]triazino[1,6-c]quinazolin-1-one
C19H16Br2N4O2S — CID 136939068
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(3,5-dibromo-4-methoxyphenyl)-3-ethylsulfanyl-2,6-dihydro-[1,2,4]triazino[1,6-c]quinazolin-1-one
6-(3,5-dibromo-4-methoxyphenyl)-3-ethylsulfanyl-2,6-dihydro-[1,2,4]triazino[1,6-c]quinazolin-1-one (PubChem CID 136939068) has the molecular formula C19H16Br2N4O2S and a molecular weight of 524.24 g/mol. Its IUPAC name is 6-(3,5-dibromo-4-methoxyphenyl)-3-ethylsulfanyl-2,6-dihydro-[1,2,4]triazino[1,6-c]quinazolin-1-one.
Molecular Properties
| Compound Name | 6-(3,5-dibromo-4-methoxyphenyl)-3-ethylsulfanyl-2,6-dihydro-[1,2,4]triazino[1,6-c]quinazolin-1-one |
|---|---|
| PubChem CID | 136939068 |
| Molecular Formula | C19H16Br2N4O2S |
| Molecular Weight | 524.24 g/mol |
| Exact Mass | 521.94 |
| IUPAC Name | 6-(3,5-dibromo-4-methoxyphenyl)-3-ethylsulfanyl-2,6-dihydro-[1,2,4]triazino[1,6-c]quinazolin-1-one |
| SMILES | CCSC1=NN2C(=c3ccccc3=NC2c2cc(Br)c(OC)c(Br)c2)C(=O)N1 |
| InChI | InChI=1S/C19H16Br2N4O2S/c1-3-28-19-23-18(26)15-11-6-4-5-7-14(11)22-17(25(15)24-19)10-8-12(20)16(27-2)13(21)9-10/h4-9,17H,3H2,1-2H3,(H,23,24,26) |
| InChIKey | MNARICAVVIEWTB-UHFFFAOYSA-N |
| XLogP | 3.12 |
| TPSA | 66.29 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 524.24 |
| LogP ≤ 5 | 3.12 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 136939068 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.